Study Watch vs Zio XT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Verily
VS
by iRhythm Technologies

AI Verdict

Both the Verily Study Watch and iRhythm Zio XT are FDA-cleared, HIPAA-compliant wearable devices leveraging AI for continuous physiological monitoring, primarily in cardiology. The Zio XT is specifically designed for clinical diagnosis of cardiac arrhythmias, offering up to 14 days of single-lead ECG monitoring for patient care. In contrast, the Study Watch is positioned for clinical research and partnerships, collecting broader physiological data from multiple sensors for investigational purposes.

Choose Study Watch if…

Choose the Verily Study Watch if your clinical research requires comprehensive, multi-modal physiological data collection beyond just ECG, such as electrodermal activity and inertial movements, over an extended period. This device is ideal for studies investigating complex physiological responses where a broad range of continuous, non-invasive sensor data is critical for analysis and hypothesis generation.

View Study Watch →

Choose Zio XT ECG Monitoring System if…

Choose the Zio XT ECG Monitoring System if your primary goal is the accurate and convenient diagnosis of cardiac arrhythmias through extended, continuous single-lead ECG monitoring in a clinical setting. This system is well-suited for patients needing up to 14 days of comfortable, water-resistant monitoring, leveraging FDA-cleared AI and expert review for efficient arrhythmia detection and reporting.

View Zio XT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Study Watch Zio XT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). Cloud-based (AWS EC2 platform), no on-premise hardware required.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Zio XT emphasizes patient comfort with its wire-free, water-resistant design, allowing for normal daily activities and boasting high patient compliance and satisfaction. While Study Watch offers a long battery life, Zio XT's features directly address ease of use and integration into a patient's daily life, which are key aspects of usability for a wearable device.

Clinical Value

Zio XT ECG Monitoring System

Zio XT is specifically designed for accurate arrhythmia detection and diagnosis over up to 14 days, leveraging FDA-cleared AI and expert review. Study Watch, while FDA-cleared and collecting multiple physiological data points, is primarily positioned for clinical research, making Zio XT's direct diagnostic application and longer monitoring period more impactful for immediate clinical value.

Pricing & Value

Zio XT ECG Monitoring System

Zio XT provides transparent pricing details for both UK and US markets, including specific CPT codes and proposed Medicare rates. In contrast, Study Watch's pricing is not publicly available and is geared towards clinical research partnerships, making it difficult to assess its value without direct engagement.

Enterprise Readiness

Zio XT ECG Monitoring System

Both tools are cloud-based, HIPAA compliant, and offer BAAs. However, Study Watch has publicly mentioned allegations of BAA/HIPAA breaches, which Verily denies, introducing a potential risk factor. Zio XT, deployed on AWS EC2, presents a standard and seemingly unblemished record in terms of enterprise compliance and deployment.

Innovation

Study Watch

Study Watch offers a broader range of physiological sensors, including ECG, heart rate, electrodermal activity, and inertial movements, providing a more comprehensive data capture for diverse research applications. While Zio XT's deep-learned AI for ECG is innovative, Study Watch's multi-sensor approach for 'AI-enabled precision health solutions' demonstrates a wider scope of innovative data collection.

Support & Docs

Zio XT ECG Monitoring System

As a commercial product directly used by healthcare professionals and patients for diagnostic purposes, Zio XT provides readily accessible instructions for use, clinical reference manuals, and patient support resources. Study Watch, being primarily a device for clinical research and partnerships, has support and documentation geared towards researchers and developers, which may not be as comprehensive for general clinical use.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Study Watch Zio XT ECG Monitoring System
Name Study Watch Zio XT ECG Monitoring System
Company Verily Life Sciences iRhythm Technologies
Primary Function Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis.
Max Monitoring Duration Continuous; battery life up to one week Up to 14 days
Sensor Type Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements); on-demand single-channel ECG. Wearable single-lead ECG biosensor (Zio biosensor).

Videos

Demos, reviews, and walkthroughs featuring Study Watch and Zio XT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Verily Study Watch is a prescription-only, sensor-based wearable device primarily for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement. It is also FDA-cleared to record, store, transfer, and display single-channel ECG rhythms for healthcare professionals and patients with known or suspected heart conditions. The Zio XT ECG Monitoring System is a wearable single-lead ECG biosensor designed for up to 14 days of continuous cardiac monitoring to detect and diagnose cardiac arrhythmias, aiming to replace or enhance standard care for patients with suspected arrhythmias.
The Verily Study Watch collects a broad range of physiological data, including ECG, heart rate, electrodermal activity, and inertial movements, offering on-demand single-channel ECG and irregular pulse monitoring. It can also monitor walking behavior, motor control, and heart rate signals for sleep and autonomic nervous system functions. In contrast, the Zio XT ECG Monitoring System is specifically designed as a wearable single-lead ECG biosensor for continuous ambulatory cardiac monitoring, focusing on beat-to-beat ECG data.
The Verily Study Watch offers continuous physiological monitoring with a battery life of up to one week. The Zio XT ECG Monitoring System provides continuous ambulatory cardiac monitoring for a longer duration, up to 14 days.
Both tools utilize cloud-based data processing with algorithms and machine learning. The Verily Study Watch employs a deep neural network algorithm for analyzing data, including for atrial fibrillation detection. The Zio XT ECG Monitoring System features a proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis, with recordings analyzed by the ZEUS algorithm and subsequently reviewed by accredited cardiac physiologists and Certified Cardiographic Technicians to generate a report.
Both companies state they are HIPAA compliant and have Business Associate Agreements (BAAs). However, Verily (Tool A) is currently facing an ongoing lawsuit alleging breaches of BAAs and HIPAA violations, which the company denies. iRhythm (Tool B) states its commitment to HIPAA compliance and undergoes regular independent third-party audits to ensure adherence.
The Verily Study Watch features an E-ink display for minimal power consumption and is designed to blend into daily life. The Zio XT ECG Monitoring System emphasizes patient comfort with a water-resistant design allowing for normal daily activities including showering, and has no external leads or wires. It also includes a patient-activated button for logging symptomatic events, contributing to its high reported patient compliance and satisfaction.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.